A Study of Cediranib and Olaparib at the Time Ovarian Cancer Worsens on Olaparib

Update Il y a 5 ans
Reference: NCT02340611

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This is a phase 2 study (the second phase in testing a new drug or drug combination) to see how useful adding investigational drug cediranib to olaparib after disease progression on olaparib alone in patients with ovarian cancer.


Inclusion criteria

  • Ovarian Cancer

Links